A Study to Investigate the Safety and Tolerability of Multiple Study Interventions in Participants With Moderate to Severe Ulcerative Colitis
NCT07747467
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Colitis, Ulcerative
Interventions
BIOLOGICAL:
Aletekitug (GSK1070806)
Sponsor
GlaxoSmithKline